“…This result is in agreement with the some earlier reported studies where no association of p.P47S polymorphism was observed in breast cancer (Alawadi et al, 2011;Al-Qasem et al, 2012), bladder cancer (Santos et al, 2011), gliomas , urinary bladder cancer (Jaiswal et al, 2011), colorectal cancer (Sameer et al, 2010) and primary open angle glaucoma patients (Daugherty et al, 2009). On the contrary, significant association of S47 has been reported in Caucasian lung cancer (Felley-Bosco et al, 1993), Brazilian brain tumor (Almeida et al, 2009) and South Indian colorectal cancer (Singamsetty et al, 2014) patients. It has been reported that the S47 phenotype has a decreased capacity to induce apoptosis, to transactivate two p53 target genes (p53AIP1 and PUMA), and to bind to MAPK1 protein as compared with the wild-type P47 phenotype (Li et al, 2005;Murphy, 2006).…”